Header image

Plenary 4

Friday, October 17, 2025
9:30 AM - 11:00 AM

Speaker

Agenda Item Image
Associate Professor Oluwaseun Falade-Nwulia
Associate Professor
Johns Hopkins University School of Medicine

Innovations in Hep C Care

9:30 AM - 9:50 AM

Biography

Dr Falade-Nwulia is an Associate Professor and director of the Center for Substance Use and Infectious Disease care integration in the Division of Infectious Diseases at the Johns Hopkins University School of Medicine. She completed her internal medicine residency and infectious at the infectious disease fellowship at the Johns Hopkins School of Medicine. Her research program focuses on development, implementation and evaluation of novel strategies integrating behavioral and biomedical interventions with an overarching goal of improving viral hepatitis, HIV and substance use outcomes. Dr. Falade-Nwulia leverages expertise from a range of disciplines including medicine, epidemiology, social sciences and technology to develop and implement low threshold integrated infectious disease and substance use care strategies. She is also an active viral hepatitis, HIV and substance use disorder care provider.
Agenda Item Image
Prof Jason Grebely
Professor
Unsw/ Kirby Institute

Effect of point-of-care RNA and dried blood spot testing on initiation of treatment among people with HCV attending needle and syringe programs: a practice-level cluster randomised controlled trial

10:30 AM - 10:45 AM

Abstract (.pdf)

Biography

Professor Jason Grebely is Head of the Hepatitis C and Drug Use Group at the Kirby Institute, UNSW Sydney, and President of INHSU. A leading expert in HCV epidemiology, testing, and treatment, his research focuses on improving care for people who use drugs, including novel diagnostic and treatment strategies.
Agenda Item Image
Prof Linda-Gail Bekker
Director & CEO
Desmond Tutu Health Foundation & Desmond Tutu HIV Centre, University of Cape Town

HIV Treatment and Prevention in People who use Drugs

9:50 AM - 10:10 AM

Biography

Prof Linda-Gail Bekker is the Chief Executive Officer of the Desmond Tutu Health Foundation and Director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa. Prof Bekker is a physician, scientist and infectious disease specialist. Her research interests include programmatic and action research around antiretroviral roll-out and TB integration, prevention of HIV in women, youth and MSM. Prof Bekker serves on numerous international scientific and advisory committees. She is a A+ rated scientist, has published >700 peer-reviewed papers.
Dr Huan-Keat Chan
Pharmacist/ Research Officer
Clinical Research Center, Sultanah Bahiyah Hospital

DETERMINANTS OF TREATMENT RESPONSE TO SOFOSBUVIR/RAVIDASVIR IN NON-CIRRHOTIC CHRONIC HEPATITIS C PATIENTS: A NESTED CASE-CONTROL ANALYSIS FROM THE EASE TRIAL

10:45 AM - 11:00 AM

Abstract (.pdf)

Biography

Chan Huan Keat, a pharmacist with a PhD in Social and Administrative Pharmacy, has over 100 publications. His work on treatment and diagnostic access helped reshape hepatitis C care in Malaysia. He previously served at CRC Hospital Sultanah Bahiyah and now advises the Director-General of Health as a special officer.
loading